Neutropenic vs non-neutropenic candidemia is treated differently. An intravenous echinocandin such as anidulafungin, caspofungin or micafungin is recommended as first-line therapy for<unk> , specifically candidemia. Oral or intravenous fluconazole is an acceptable alternative. The lipid formulation amphotericin B is a reasonable alternative if there is limited antifungal availability, antifungal resistance, or antifungal intolerance.
Fungemia
Siderosis
Granulocytosis
Chyluria
Choroideremia
Agranulocytosis
Choluria
Kyphosis